JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

C5385 Butenoyl PAF

Summary: PAF receptor agonist

≥5 mg/mL
C5613 LY83583

Summary: inhibitor of soluble guanylate cyclase and of cGMP production

≤3.8 mg/mL
A1067 eukaryotic translation elongation factor 1 alpha 1 (EEF1A1) (387-394) [Multiple species]

Summary: Elongation factor-1 subunit

≥91.8 mg/mL
A2511 Carbenicillin, Disodium Salt

Summary: Inhibits the cell-wall synthesis,antibiotic

insoluble in EtOH; ≥8.64 mg/mL
A8180 KN-62
2 Citation

Target: Ca2 /calmodulin-dependent protein kinases (CaMKs)|P2X Receptors

Summary: CaM kinase II inhibitor

≥36.1 mg/mL
A8192 Staurosporine
20 Citation

Summary: serine/threonine protein kinases inhibitor

insoluble in H2O; insoluble in EtOH; ≥11.66 mg/mL
B3694 K-Ras(G12C) inhibitor 6

Target: KRAS G12C

Summary: K-Ras (G12C) inhibitor

insoluble in H2O; insoluble in EtOH; ≥20.25 mg/mL
B4635 CZC-25146

Target: LRRK2

Summary: LRRK2 inhibitor

≥24.45 mg/mL
B4654 AM580

Target: RARs

Summary: Selective RARα agonist

insoluble in H2O; ≥14.3 mg/mL
B4675 GW311616

Summary: inhibitor of human neutrophil elastase(HNE)

Soluble in DMSO